Induction and maintenance of diverse humoral and cellular immune responses following influenza A virus infection and vaccination
Influenza A virus (IAV) is a major cause of serious respiratory illness worldwide, leading to approximately 5 million severe cases and 500,000 deaths per year. Given the disease severity, associated economic costs, and recent appearance of novel IAV strains, there is a renewed interest in developing...
Main Author: | Zacharias, Zeb Ralph |
---|---|
Other Authors: | Legge, Kevin L. |
Format: | Others |
Language: | English |
Published: |
University of Iowa
2018
|
Subjects: | |
Online Access: | https://ir.uiowa.edu/etd/6669 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=8168&context=etd |
Similar Items
-
Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections
by: Zeb R. Zacharias, et al.
Published: (2018-08-01) -
T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine
by: Anna Schmidt, et al.
Published: (2021-01-01) -
Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
by: Angela Choi, et al.
Published: (2020-06-01) -
Generation of T Cell Responses and Immunological Memory Following Influenza Infection and Vaccination in Early Life and Adulthood
by: Zens, Kyra Denise
Published: (2017) -
Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
by: Pavimol Angsantikul, et al.
Published: (2015-10-01)